Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
222 Leser
Artikel bewerten:
(1)

November International Hyperhidrosis Awareness Month: No Sweat, No Stress With the miraDry Treatment

LONDON, Oct. 31, 2019 /PRNewswire/ -- miraDry is Supporting International Hyperhidrosis Awareness Month and the 'Know Sweat' Campaign from the International Hyperhidrosis Society

miraDry is the ONLY FDA-cleared, in-clinic treatment, that can dramatically reduce underarm sweat in as little as one appointment[1]. It is available in over 84 countries including clinics in the UK and Ireland.

Hyperhidrosis is a medical condition which affects up to 4.8% of the population[2]. It manifests as extreme, uncontrollable sweating beyond what's considered "normal" or necessary as a reaction to heat, exercise or stress. According to latest research from Reports and Data[3], the global hyperhidrosis treatment market was valued at USD 1.17 billion in 2018 and is expected to reach USD 1.87 billion by 2026.

miraDry overview:

  • miraDry is a revolutionary and non-surgical treatment with permanent and immediate results
  • The innovative system uses thermal energy to non-invasively target and eliminate sweat glands found in the underarm
  • Clinically proven to reduce sweat production by 82% on average
  • 1 in 10 people admit that they're bothered by underarm sweat which has an impact on their confidence [4], [5]
  • 150,000+ treatments performed worldwide with excellent safety record

Available at clinics in the UK and Ireland

Prices from: £1495 / €1900

The miraDry system is intended for use by health care professionals for treatment of primary axillary hyperhidrosis in adults. Patient results and experience may vary. miraDry and No Sweat No Stress is a trademark of miraDry, Inc. © 2019 miraDry, Inc. All rights reserved.

@miradry_uk / https://www.miradry.com/en-gb/

References:

  1. Lupin M, Hong HC, O'Shaughnessy KF. Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device. Dermatol Surg. 2014;40(7):805-807
  2. https://www.sweathelp.org/sweat-help-home/2019knowsweatmonth.html
  3. https://www.reportsanddata.com/report-detail/hyperhidrosis-treatment-market
  4. Data on file. miraDry, Inc.
  5. United States Census Bureau. https://www.census.gov/en.html. Accessed 6/12/2018

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2019 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.